Photo by cdc from unsplash
Most Crohn's Disease (CD) patients will require surgical intervention over their lifetime, with considerably high rates of post‐operative complications. Risk stratification with reliable prognostic tools may facilitate clinical decision making… Click to show full abstract
Most Crohn's Disease (CD) patients will require surgical intervention over their lifetime, with considerably high rates of post‐operative complications. Risk stratification with reliable prognostic tools may facilitate clinical decision making in these patients. Blood cell interaction based inflammatory markers have proven useful in predicting patient outcomes in oncological and benign diseases. The aim of this study was to investigate their prognostic value in CD patients undergoing surgery.
Journal Title: Anz Journal of Surgery
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!